Nanobiotechnologists have devised a programmable DNA self-assembly strategy that solves the key challenge of robust nucleation control and paves the way for applications such as ultrasensitive diagnostic biomarker detection and scalable fabrication of micrometer-sized structures with nanometer-sized features.